Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jerika V. Nguyen, Tian Yaw & Holly Gratton. (2021) Incidence of neurobehavioral side effects associated with levetiracetam compared to phenytoin in traumatic brain injury patients. Brain Injury 35:8, pages 902-906.
Read now
Read now
Zhan-Miao Yi, 1–3, Cheng Wen, Ting Cai, Lu Xu, Xu-Li Zhong, Si-Yan Zhan & Suo-Di Zhai. (2019) Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles. Neuropsychiatric Disease and Treatment 15, pages 1-19.
Read now
Read now
Jeroen G. V. Habets, Albert F. G. Leentjens & Olaf E. M. G. Schijns. (2017) Serious and reversible levetiracetam-induced psychiatric symptoms after resection of frontal low-grade glioma: two case histories. British Journal of Neurosurgery 31:4, pages 471-473.
Read now
Read now
Johan A.F. Koekkoek, Linda Dirven & Martin J.B. Taphoorn. (2017) The withdrawal of antiepileptic drugs in patients with low-grade and anaplastic glioma. Expert Review of Neurotherapeutics 17:2, pages 193-202.
Read now
Read now
Articles from other publishers (48)
Ying Wang, Wenting Huang, Jia Li, Shumin Mao, Wenqiang Fang & Huiqin Xu. (2023) A case of Gitelman syndrome with homozygous SLC12A3 deletion presenting with epilepsy. Acta Epileptologica 5:1.
Crossref
Crossref
Jacob S Kazmi, Nabila Albarghouthy & Randy Ramsaywak. (2023) Levetiracetam-Induced Rhabdomyolysis Reversed by Discontinuation: A Case Report. Cureus.
Crossref
Crossref
Corina Andrei, Dragos Paul Mihai, Georgiana Nitulescu, Anca Ungurianu, Denisa Marilena Margina, George Mihai Nitulescu, Octavian Tudorel Olaru, Radu Mihai Busca & Anca Zanfirescu. (2023) Cetirizine and Levetiracetam as Inhibitors of Monoacylglycerol Lipase: Investigating Their Repurposing Potential as Novel Osteoarthritic Pain Therapies. Pharmaceuticals 16:11, pages 1563.
Crossref
Crossref
Jon Davis Perkins, Mohamed S. Abdelmoneim, Stacy Schantz Wilkins, Saadat Kamran, Boulenouar Mesraoua, Gayane Melikyan, Abdulraheem Alrabi, Ahmed El-Bardissy, Osama Elalamy & Hassan Jassim Al Hail. (2023) Dosage, time, and polytherapy dependent effects of different levetiracetam regimens on cognitive function. Epilepsy & Behavior 148, pages 109453.
Crossref
Crossref
Jane Marice S. Pascual, Karen Joy B. Adiao & Mario B. PradoJrJr. (2023) Efficacy and Safety of Levetiracetam on the Treatment of Spasticity in Neurologic Disorders: a Systematic Review. SN Comprehensive Clinical Medicine 5:1.
Crossref
Crossref
Arvinpreet Kour & Ajaydeep Singh. (2023) Levetiracetam-induced drug reaction: violaceous discrete maculopapular rash: A case report. Apollo Medicine 20:1, pages 83.
Crossref
Crossref
Maryam Rahman, Stephan Eisenschenk, Kaitlyn Melnick, Yu Wang, Shelley Heaton, Ashley Ghiaseddin, Marcia Hodik, Nina McGrew, Jessica Smith, Greg Murad, Steven Roper & Jean Cibula. (2023) Duration of Prophylactic Levetiracetam After Surgery for Brain Tumor: A Prospective Randomized Trial. Neurosurgery 92:1, pages 68-74.
Crossref
Crossref
Niklas Gremke, Marcel Printz, Leona Möller, Conrad Ehrenberg, Karel Kostev & Matthias Kalder. (2022) Association between anti-seizure medication and the risk of lower urinary tract infection in patients with epilepsy. Epilepsy & Behavior 135, pages 108910.
Crossref
Crossref
Ángel JM Gargiulo, Mercedes Sarudiansky, Alejandro Videla, Nicolás Lombardi, Guido P Korman, Silvia Oddo & Luciana D´Alessio. (2022) Perceived stress, resilience, and stress coping in patients with drug resistant epilepsy and functional dissociative seizures. Seizure 101, pages 141-148.
Crossref
Crossref
Khadija M Alshehabi, Sumayah Askandarani & Zainab A Alkhalifah. (2022) Suspected Levetiracetam-Induced Acute Rhabdomyolysis in a Patient With Retinoblastoma: A Case Report and Literature Review. Cureus.
Crossref
Crossref
Paige Coughlin, Goonja Patel, Jessica Vadaketh & Ramesh Pandit. (2022) A Rare Case of Levetiracetam-Induced Refractory Hypokalemia. Cureus.
Crossref
Crossref
Brittany M. Kasturiarachi, Rashi Krishnan, Diana L. Alsbrook, Brittany Hudson, Hallie Kelly, Caitlin E. Moran, Khalid Alsherbini & G. Morgan Jones. (2022) Evaluation of the Safety of Rapid Administration of Undiluted High-Dose Intravenous Levetiracetam. The Neurohospitalist 12:2, pages 227-230.
Crossref
Crossref
J James, J Jose & VA Gafoor. (2022) Levetiracetam-induced gingival hyperplasia. Journal of Postgraduate Medicine 68:3, pages 168.
Crossref
Crossref
Tatiani Soultana Ilia, Pinelopi Dragoumi, Stavroula Papanikolopoulou, Dimitrios G. Goulis, Evangelos Pavlou & Dimitrios Zafeiriou. (2022) Is the prevalence of thyroid disease higher in children receiving antiepileptic medication? A systematic review and meta-analysis. Seizure 94, pages 117-125.
Crossref
Crossref
Seung Yeon Jung, Yoon Young Yi & Joon Won Kang. (2021) Once-Daily Extended-Release Levetiracetam Improves Medication Compliance in Adolescent Epilepsy Patients. Annals of Child Neurology 29:2, pages 61-67.
Crossref
Crossref
Maria Luiza Giraldes de MANREZA, Tatiane Amaral PAN, Eduardo Quinalha CARBONE, Antonio Carlos Amedeo VATTIMO, Renata HERRERA, Douglas Costa MORAIS, Rita Antonelli CARDOSO, Glenda Corrêa Borges de LACERDA, Katia LIN, Frederico Nakane NAKANO, Pedro André KOWACS, André Luis Fernandes PALMINI, Adélia Maria de Miranda Henriques SOUZA, Stevin ZUNG & Elza Márcia Targas YACUBIAN. (2021) Efficacy and safety of levetiracetam as adjunctive therapy for refractory focal epilepsy. Arquivos de Neuro-Psiquiatria 79:4, pages 290-298.
Crossref
Crossref
Alejandro Ballvé, Javier Salas‐Puig, Manuel Quintana, Daniel Campos, Arnau Llauradó, Miquel Raspall, Elena Fonseca, Laura Abraira, Estevo Santamarina & Manuel Toledo. (2021) Levetiracetam as first‐line monotherapy for Idiopathic Generalized Epilepsy in women. Acta Neurologica Scandinavica 143:4, pages 407-412.
Crossref
Crossref
Jana Heidemann, Bettina Schmitz & Karel Kostev. (2021) Association between antiseizure medication use and risk of urinary tract infection: A case–control study. Epilepsy & Behavior 115, pages 107502.
Crossref
Crossref
Ljiljana Djekic, Bojan Marković, Ana Micov, Maja Tomić, Uroš Pecikoza & Radica Stepanović-Petrović. (2020) Percutaneous delivery of levetiracetam as an alternative to topical nonsteroidal anti-inflammatory drugs: formulation development, in vitro and in vivo characterization. Drug Delivery and Translational Research 11:1, pages 227-241.
Crossref
Crossref
Meltem Direk, Serdar Epcacan, Zerrin Epcacan, Didem Derici Yildirim & Cetin Okuyaz. (2020) Efficacy of levetiracetam in the treatment of Sydenham chorea. Pediatrics International 62:11, pages 1264-1268.
Crossref
Crossref
Camila Cortes & Carla Manterola. (2020) Behavioral alterations associated with levetiracetam in pediatric epilepsy. Epilepsy & Behavior 112, pages 107472.
Crossref
Crossref
Joshua M. DeMott, Giles W. Slocum, Michael Gottlieb & Gary D. Peksa. (2020) Levetiracetam vs. phenytoin as 2nd-line treatment for status epilepticus: A systematic review and meta-analysis. Epilepsy & Behavior 111, pages 107286.
Crossref
Crossref
Oluwaseun Ogunsakin, Terence Tumenta, Scarlet Louis-Jean, Ayesha Mahbub, Peterson Rabel, Tolu Olupona & Shaheen Alam. (2020) Levetiracetam Induced Behavioral Abnormalities in a Patient with Seizure Disorder: A Diagnostic Challenge. Case Reports in Psychiatry 2020, pages 1-4.
Crossref
Crossref
Ying Xu, Maree L. Hackett, Armin Nikpour, Ernest Somerville, Andrew Bleasel, Carol Ireland, Daniel F. Ghougassian, Craig S. Anderson & Nick Glozier. (2020) Course and impact of sleep disturbance in newly diagnosed epilepsy: A prospective registry study. Clinical Neurology and Neurosurgery 195, pages 105963.
Crossref
Crossref
Anthoulla MohamudallyKatherine Clark. (2020) Levetiracetam at the End of Life: A Case Report and Discussion. Journal of Palliative Medicine 23:7, pages 995-997.
Crossref
Crossref
Bshra Ali A. Alsfouk, Martin J. Brodie, Matthew Walters, Patrick Kwan & Zhibin Chen. (2020) Tolerability of Antiseizure Medications in Individuals With Newly Diagnosed Epilepsy. JAMA Neurology 77:5, pages 574.
Crossref
Crossref
Muhammed Rashid, Asha K Rajan, Manik Chhabra & Ananth Kashyap. (2020) Levetiracetam and cutaneous adverse reactions: A systematic review of descriptive studies. Seizure 75, pages 101-109.
Crossref
Crossref
Kristin F Phillips & Laxmikant S Deshpande. (2020) Calcium Hypothesis of Gulf War Illness: Role of Calcium Ions in Neurological Morbidities in a DFP-Based Rat Model for Gulf War Illness. Neuroscience Insights 15, pages 263310552097984.
Crossref
Crossref
Roa'a W. Jaradat, Amro B. Lahlouh, Osama Y. Alshogran, Belal A. Aldabbour & Abedallah AK. Balusha. (2019) Nosocomial Infections among Patients with Intracranial Hemorrhage: A Retrospective Data Analysis of Predictors and Outcomes. Clinical Neurology and Neurosurgery 182, pages 158-166.
Crossref
Crossref
A. Thelengana, Garima Shukla, Achal Srivastava, Mamta Bhushan Singh, Anupama Gupta, Roopa Rajan, Deepti Vibha, Awadh Kishor Pandit & Kameshwar Prasad. (2019) Cognitive, behavioural and sleep-related adverse effects on introduction of levetiracetam versus oxcarbazepine for epilepsy. Epilepsy Research 150, pages 58-65.
Crossref
Crossref
Raj G. KumarKristen B. BreslinAnne C. RitterYvette P. ConleyAmy K. Wagner. (2019) Variability with Astroglial Glutamate Transport Genetics Is Associated with Increased Risk for Post-Traumatic Seizures. Journal of Neurotrauma 36:2, pages 230-238.
Crossref
Crossref
Ali Ercan Altınöz, Şengül Tosun Altınöz, Başak Güzel Biltekin & Murat Can Kaya. (2019) Levetiracetam induced hypomania: a case report. Therapeutic Advances in Drug Safety 10, pages 204209861987675.
Crossref
Crossref
Cerine C. Hansen, Hanna Ljung, Eylert Brodtkorb & Arne Reimers. (2018) Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and Perampanel. Behavioural Neurology 2018, pages 1-18.
Crossref
Crossref
Tony Wu, Siew-Na Lim, Jing-Jane Tsai, Yao-Chung Chuang, Chin-Wei Huang, Chun-Chieh Lin, Chang-Hung Hsu, Hong-Chung Fung & Chih-Hong Lee. (2018) A randomized, double-blind, double-dummy, multicenter trial comparing the efficacy and safety of extended- and immediate-release levetiracetam in people with partial epilepsy. Seizure 62, pages 84-90.
Crossref
Crossref
Hussein Algahtani, Siham Marghalani, Mohamed Satti & Bader Shirah. (2017) Levetiracetam-Induced Skin Hyperpigmentation: An Extremely Rare Undesirable Side Effect. Journal of Epilepsy Research 7:2, pages 106-108.
Crossref
Crossref
Gaetano Zaccara, Fabio Giovannelli, Filippo Sean Giorgi, Valentina Franco, Sara Gasparini & Francesco Mandò Tacconi. (2017) Do antiepileptic drugs increase the risk of infectious diseases? A meta-analysis of placebo-controlled studies. British Journal of Clinical Pharmacology 83:9, pages 1873-1879.
Crossref
Crossref
Hesham A. Salem & Muhammad Y. Al-Shorbagy. (2017) Evaluation of the relaxant effect of levetiracetam on isolated rat duodenum. Fundamental & Clinical Pharmacology 31:1, pages 75-82.
Crossref
Crossref
Ugur Damar, Roman Gersner, Joshua T. Johnstone, Steven Schachter & Alexander Rotenberg. (2017) Huperzine A: A promising anticonvulsant, disease modifying, and memory enhancing treatment option in Alzheimer’s disease. Medical Hypotheses 99, pages 57-62.
Crossref
Crossref
Nico Sollmann, Noriko Tanigawa, Lucia Bulubas, Jamil Sabih, Claus Zimmer, Florian Ringel, Bernhard Meyer & Sandro M. Krieg. (2016) Clinical Factors Underlying the Inter-individual Variability of the Resting Motor Threshold in Navigated Transcranial Magnetic Stimulation Motor Mapping. Brain Topography 30:1, pages 98-121.
Crossref
Crossref
Yu-Xing Ge, Xiang-Zhu Tian, Ying-Ying Lin & Xue-Yuan Liu. (2016) Chronic treatment with levetiracetam reverses deficits in hippocampal LTP in vivo in experimental temporal lobe epilepsy rats. Neuroscience Letters 628, pages 194-200.
Crossref
Crossref
Fa-Yun Hu, Wei Wang, Jie-Chuan Ren, Dong-Mei An, Jia-Ni Chen & Dong Zhou. (2016) Levetiracetam-induced cutaneous adverse drug reactions were not associated with HLA genes in a small sample of Chinese patients with epilepsy. Epilepsy Research 124, pages 12-15.
Crossref
Crossref
Martin J. Brodie, Frank Besag, Alan B. Ettinger, Marco Mula, Gabriella Gobbi, Stefano Comai, Albert P. Aldenkamp & Bernhard J. Steinhoff. (2016) Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review. Pharmacological Reviews 68:3, pages 563-602.
Crossref
Crossref
Ariel Levy & Robert Chen. (2016) Myoclonus: Pathophysiology and Treatment Options. Current Treatment Options in Neurology 18:5.
Crossref
Crossref
Jun Ju, Li-Ping Zou, Xiu-Yu Shi, Lin-Yan Hu & Ling-Yu Pang. (2016) Levetiracetam. American Journal of Therapeutics 23:2, pages e624-e627.
Crossref
Crossref
Alexander B. Kowski, Florian Weissinger, Verena Gaus, Pawel Fidzinski, Florian Losch & Martin Holtkamp. (2016) Specific adverse effects of antiepileptic drugs — A true-to-life monotherapy study. Epilepsy & Behavior 54, pages 150-157.
Crossref
Crossref
Nimish A. Mohile. (2016) How I treat glioblastoma in older patients. Journal of Geriatric Oncology 7:1, pages 1-6.
Crossref
Crossref
Julio Cesar Magalhães, Mariana Gongora, Renan Vicente, Juliana Bittencourt, Guaraci Tanaka, Bruna Velasques, Silmar Teixeira, Gledys Morato, Luis F. Basile, Oscar Arias-Carrión, Fernando A.M.S Pompeu, Mauricio Cagy & Pedro Ribeiro. (2015) The Influence of Levetiracetam in Cognitive Performance in Healthy Individuals: Neuropsychological, Behavioral and Electrophysiological Approach. Clinical Psychopharmacology and Neuroscience 13:1, pages 83-93.
Crossref
Crossref
Kelly Mills & Zoltan Mari. (2014) An Update and Review of the Treatment of Myoclonus. Current Neurology and Neuroscience Reports 15:1.
Crossref
Crossref